Patent ID: 9011881
Filing Date: 2015-04-21
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition for treating urinary system disorders, comprising a carbon material and a water-containing carrier; the carbon material being carried by the water-containing carrier; the pharmaceutical composition having a carbon content greater than 60% by element weight; both of the carbon material and the water-containing carrier constitute a pharmaceutically acceptable water-containing carrier carrying the carbon material; the carbon material having a diameter falling within a range from 2 nm to 2 mm; wherein the carbon material has a carbon layer stack thickness (Lc) falling within a range from 1 nm to 1000 mm; the carbon material is one selected from the group consisting of carbon fiber, active carbon fiber, active carbon, nano-carbon tube, carbon nanocapsule, coke ball, carbon black, and a combination of the above; wherein the carbon material further includes a metal particle combined with the carbon material, and the metal particle comprising silver, and the metal particle has a diameter falling within a range from 2 nm to 2 mm, and occupies a percentage by weight of the carbon material below 20 wt %; the carbon material in the pharmaceutical composition contacting a bladder or related tissues of the bladder in an animal body; the water-containing carrier is selected from the group consisting of a buffer solution, the buffer solution containing an antibiotic medicament, the buffer solution containing cystitis medication, and the buffer solution containing both the antibiotic and the cystitis medication; and the pharmaceutical composition reducing symptoms of cystitis.